insitro to translate $143 million B round into drug discovery platform

AI and machine learning company insitro is looking to drug discovery as its next phase of platform development with an Andreessen Horowitz-led $143 million series B round.

The company has spent the two years since its inception modeling diseases and identifying targets, and plans to begin translating that data into therapeutic programs (see “insitro: Machine Learning with Designated Data”). ...